293 related articles for article (PubMed ID: 9024713)
1. Expression of scatter factor and c-met receptor in benign and malignant breast tissue.
Jin L; Fuchs A; Schnitt SJ; Yao Y; Joseph A; Lamszus K; Park M; Goldberg ID; Rosen EM
Cancer; 1997 Feb; 79(4):749-60. PubMed ID: 9024713
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.
Tuck AB; Park M; Sterns EE; Boag A; Elliott BE
Am J Pathol; 1996 Jan; 148(1):225-32. PubMed ID: 8546209
[TBL] [Abstract][Full Text] [Related]
3. bcl-2 expression in the spectrum of preinvasive breast lesions.
Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
[TBL] [Abstract][Full Text] [Related]
4. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of c-Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue.
Lindemann K; Resau J; Nährig J; Kort E; Leeser B; Annecke K; Welk A; Schäfer J; Vande Woude GF; Lengyel E; Harbeck N
Histopathology; 2007 Jul; 51(1):54-62. PubMed ID: 17593080
[TBL] [Abstract][Full Text] [Related]
6. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukin-1beta in human breast carcinoma.
Jin L; Yuan RQ; Fuchs A; Yao Y; Joseph A; Schwall R; Schnitt SJ; Guida A; Hastings HM; Andres J; Turkel G; Polverini PJ; Goldberg ID; Rosen EM
Cancer; 1997 Aug; 80(3):421-34. PubMed ID: 9241076
[TBL] [Abstract][Full Text] [Related]
8. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD44s, CD44v6, and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast.
Afify A; McNiel MA; Braggin J; Bailey H; Paulino AF
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):121-7. PubMed ID: 18227732
[TBL] [Abstract][Full Text] [Related]
10. Expression of the c-Met/HGF receptor in human breast carcinoma: correlation with tumor progression.
Beviglia L; Matsumoto K; Lin CS; Ziober BL; Kramer RH
Int J Cancer; 1997 Jun; 74(3):301-9. PubMed ID: 9221809
[TBL] [Abstract][Full Text] [Related]
11. Expression of epithelial mucins Muc1, Muc2, and Muc3 in ductal carcinoma in situ of the breast.
Diaz LK; Wiley EL; Morrow M
Breast J; 2001; 7(1):40-5. PubMed ID: 11348414
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of MUC1 mucin in ductal hyperplasia and ductal carcinoma In situ of the breast.
Mommers EC; Leonhart AM; von Mensdorff-Pouilly S; Schol DJ; Hilgers J; Meijer CJ; Baak JP; van Diest PJ
Int J Cancer; 1999 Oct; 84(5):466-9. PubMed ID: 10502721
[TBL] [Abstract][Full Text] [Related]
13. Nm23 protein expression in ductal in situ and invasive human breast carcinoma.
Royds JA; Stephenson TJ; Rees RC; Shorthouse AJ; Silcocks PB
J Natl Cancer Inst; 1993 May; 85(9):727-31. PubMed ID: 8386774
[TBL] [Abstract][Full Text] [Related]
14. Microvessel density and distribution in ductal carcinoma in situ of the breast.
Guidi AJ; Fischer L; Harris JR; Schnitt SJ
J Natl Cancer Inst; 1994 Apr; 86(8):614-9. PubMed ID: 7511693
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor/scatter factor expression in human mammary epithelium.
Wang Y; Selden AC; Morgan N; Stamp GW; Hodgson HJ
Am J Pathol; 1994 Apr; 144(4):675-82. PubMed ID: 8160769
[TBL] [Abstract][Full Text] [Related]
16. Expression of scatter factor in human bladder carcinoma.
Joseph A; Weiss GH; Jin L; Fuchs A; Chowdhury S; O'Shaugnessy P; Goldberg ID; Rosen EM
J Natl Cancer Inst; 1995 Mar; 87(5):372-7. PubMed ID: 7853418
[TBL] [Abstract][Full Text] [Related]
17. p53 protein expression in ductal carcinoma in situ (DCIS) of the breast.
Rajan PB; Scott DJ; Perry RH; Griffith CD
Breast Cancer Res Treat; 1997 Feb; 42(3):283-90. PubMed ID: 9065612
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of scatter factor and its receptor (c-met) in oral squamous cell carcinoma.
Marshall DD; Kornberg LJ
Laryngoscope; 1998 Sep; 108(9):1413-7. PubMed ID: 9738769
[TBL] [Abstract][Full Text] [Related]
19. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
Costantini V; Sidoni A; Deveglia R; Cazzato OA; Bellezza G; Ferri I; Bucciarelli E; Nenci GG
Cancer; 1996 Mar; 77(6):1079-88. PubMed ID: 8635127
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 protein in benign epithelial hyperplasia, atypical ductal hyperplasia, non-invasive and invasive mammary carcinoma: an immunohistochemical study.
Umekita Y; Takasaki T; Yoshida H
Virchows Arch; 1994; 424(5):491-4. PubMed ID: 7913368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]